CLEVELAND, April 30 /PRNewswire-FirstCall/ -- Cleveland BioLabs, Inc. (NASDAQ:CBLI)(BostonStockExchange:CFB), today announced that it will have a booth and poster presentation at the National Radiological Emergency Preparedness (REP) Conference, April 30-May 3, in Newport Beach, CA.

The purpose of the conference is to provide a professional forum for individuals and agencies involved in radiological emergency preparedness and response. Attendees are typically from federal, state, and local emergency management agencies, radiological health programs, nuclear power utilities, and other organizations involved in radiological emergency preparedness and response.

The National REP Conference is a not-for-profit national organization, run by a Steering Committee and members representing states of ten FEMA regions, and a Federal Liaison.

More information on the conference may be accessed at:

About Cleveland BioLabs, Inc.

Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. The Company has strategic partnerships with the Cleveland Clinic Foundation, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Research Radiobiology Institute. To learn more about Cleveland BioLabs Inc., please visit the company's website at

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Some of the factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in our filings with the Securities and Exchange Commission.

    The Global Consulting Group
    Rachel Levine
    T: (646) 284-9439